{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:09:10Z","timestamp":1782842950642,"version":"3.54.5"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e27507","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T23:11:52Z","timestamp":1709334712000},"page":"e27507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of machine learning-based malignant pericardial effusion-related model in breast cancer: Implications for clinical significance, tumor immune and drug-therapy"],"prefix":"10.1016","volume":"10","author":[{"given":"Wendi","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taolan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2024.e27507_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113161","article-title":"SEC14L3 plays a tumor-suppressive role in breast cancer through a Wnt\/beta-catenin-related way","volume":"417","author":"Zhu","year":"2022","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27507_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/15748928113086660046","article-title":"Breast cancer: current developments in molecular approaches to diagnosis and treatment","volume":"9","author":"de la Mare","year":"2014","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"issue":"3 Suppl","key":"10.1016\/j.heliyon.2024.e27507_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/cncr.11126","article-title":"The biology of breast carcinoma","volume":"97","author":"Keen","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.heliyon.2024.e27507_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.840826","article-title":"The influence of Modifiable factors on breast and prostate cancer risk and disease progression","volume":"13","author":"Tan","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.heliyon.2024.e27507_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-030-20301-6_4","article-title":"Breast cancer: current perspectives on the disease status","volume":"1152","author":"Fahad Ullah","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.heliyon.2024.e27507_bib6","article-title":"Advanced approaches to breast cancer classification and diagnosis","volume":"11","author":"Zubair","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27507_bib7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1186\/s12885-020-07559-w","article-title":"Prognostic role of vitamin D receptor in breast cancer: a systematic review and meta-analysis","volume":"20","author":"Xu","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e27507_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejca.2020.05.014","article-title":"Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: analysis of 244 stage I-III patients treated with standard therapy","volume":"136","author":"Dieci","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e27507_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/aogs.14316","article-title":"The prognostic value of the number of positive lymph nodes and the lymph node ratio in early-stage cervical cancer","volume":"101","author":"Olthof","year":"2022","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e27507_bib10","article-title":"Cytological grading of breast carcinomas and its prognostic implications","volume":"14","author":"Rajendran","year":"2022","journal-title":"Cureus"},{"issue":"6 Suppl","key":"10.1016\/j.heliyon.2024.e27507_bib11","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/1097-0142(19920915)70:4+<1755::AID-CNCR2820701617>3.0.CO;2-G","article-title":"Prognostic factors. Stage and receptor status in breast cancer","volume":"70","author":"Donegan","year":"1992","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27507_bib12","first-page":"e6627","article-title":"Etiology of pericardial effusion and outcomes post pericardiocentesis in the western region of Saudi Arabia: a single-center experience","volume":"12","author":"Albugami","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.heliyon.2024.e27507_bib13","series-title":"Effusive-constrictive Pericarditis in the Spectrum of Pericardial Compressive Syndromes","author":"Janus","year":"2021"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e27507_bib14","article-title":"Subacute cardiac tamponade with massive pericardial effusion","volume":"14","author":"Hein","year":"2022","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27507_bib15","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1148\/rg.276065002","article-title":"Imaging findings in cardiac tamponade with emphasis on CT","volume":"27","author":"Restrepo","year":"2007","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27507_bib16","doi-asserted-by":"crossref","first-page":"307 e1","DOI":"10.1016\/j.repc.2016.03.014","article-title":"Pericardial mesothelioma presenting as a suspected ST-elevation myocardial infarction","volume":"36","author":"Barroso","year":"2017","journal-title":"Rev. Port. Cardiol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e27507_bib17","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1200\/JCO.1985.3.12.1678","article-title":"Tetracycline sclerosis in the management of malignant pericardial effusion","volume":"3","author":"Shepherd","year":"1985","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.heliyon.2024.e27507_bib18","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.jacc.2020.08.003","article-title":"Effect of anti-inflammatory drugs on clinical outcomes in patients with malignant pericardial effusion","volume":"76","author":"Kim","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"22","key":"10.1016\/j.heliyon.2024.e27507_bib19","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1200\/JCO.2005.00.745","article-title":"Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion","volume":"23","author":"Gornik","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e27507_bib20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2015.06.1332","article-title":"Outcomes of cancer patients undergoing percutaneous pericardiocentesis for pericardial effusion","volume":"66","author":"El Haddad","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27507_bib21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3892\/ol.2015.3305","article-title":"Differential expression of vascular endothelial growth factor-A, -C and -D for the diagnosis and prognosis of cancer patients with malignant effusions","volume":"10","author":"Jia","year":"2015","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27507_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7150\/ijbs.66536","article-title":"Identification and validation of a prognostic model based on three MVI-related genes in hepatocellular carcinoma","volume":"18","author":"Tang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"19","key":"10.1016\/j.heliyon.2024.e27507_bib23","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.7150\/thno.47938","article-title":"Identification of a tumor microenvironment-relevant gene set-based prognostic signature and related therapy targets in gastric cancer","volume":"10","author":"Cai","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.heliyon.2024.e27507_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-2407-11-143","article-title":"Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization","volume":"11","author":"Kao","year":"2011","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e27507_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa427","article-title":"HCC subtypes based on the activity changes of immunologic and hallmark gene sets in tumor and nontumor tissues","volume":"22","author":"Gong","year":"2021","journal-title":"Briefings Bioinf."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e27507_bib26","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27507_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ogc.2021.11.010","article-title":"Disparities in breast cancer","volume":"49","author":"Grabinski","year":"2022","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e27507_bib28","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e27507_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.heliyon.2024.e27507_bib30","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3389\/fonc.2019.01314","article-title":"An immune-related signature predicts survival in patients with lung adenocarcinoma","volume":"9","author":"Zhang","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2024.e27507_bib31","article-title":"Identification of CDK2-related immune forecast model and ceRNA in lung adenocarcinoma, a pan-cancer analysis","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27507_bib32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12967-022-03630-1","article-title":"System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma","volume":"20","author":"Yan","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e27507_bib33","article-title":"A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27507_bib34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1186\/s12885-021-08341-2","article-title":"Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e27507_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.845093","article-title":"Development of a novel immune-related gene prognostic index for breast cancer","volume":"13","author":"Yao","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e27507_bib36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27507_bib37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.tplants.2019.01.003","article-title":"Copy number variation in domestication","volume":"24","author":"Lye","year":"2019","journal-title":"Trends Plant Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e27507_bib38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.heliyon.2024.e27507_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinf."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27507_bib40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"43","key":"10.1016\/j.heliyon.2024.e27507_bib41","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2024.e27507_bib42","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e27507_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27507_bib44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e27507_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e27507_bib46","article-title":"A nomogram model to predict prognosis of patients with genitourinary sarcoma","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27507_bib47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12964-021-00814-y","article-title":"Comprehensive analysis of a TNF family based-signature in diffuse gliomas with regard to prognosis and immune significance","volume":"20","author":"Wang","year":"2022","journal-title":"Cell Commun. Signal."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e27507_bib48","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.trecan.2020.02.007","article-title":"Promoter DNA hypermethylation and paradoxical gene activation","volume":"6","author":"Smith","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.heliyon.2024.e27507_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102887","article-title":"Postmastectomy radiation therapy in early breast cancer: utility or futility?","volume":"147","author":"Montero","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e27507_bib50","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/PAS.0000000000001669","article-title":"Survival and prognostic factors of adult intracranial ependymoma: a single-institutional analysis of 236 patients","volume":"45","author":"Zhao","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.heliyon.2024.e27507_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9441896","article-title":"A novel systematic oxidative stress score predicts the prognosis of patients with operable breast cancer","volume":"2021","author":"Zhang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e27507_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182953","article-title":"Lymph node status have a prognostic impact in breast cancer patients with distant metastasis","volume":"12","author":"Tang","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27507_bib53","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbcan.2018.04.006","article-title":"Microcalcifications in breast cancer: from pathophysiology to diagnosis and prognosis","volume":"1869","author":"O'Grady","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27507_bib54","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27507_bib55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3892\/ijo.2021.5174","article-title":"Novel therapies for malignant pleural effusion: anti-angiogenic therapy and immunotherapy","volume":"58","author":"He","year":"2021","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.heliyon.2024.e27507_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106802","article-title":"Update on the diagnosis and management of malignant pleural effusions","volume":"196","author":"Bashour","year":"2022","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27507_bib57","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.annonc.2019.11.006","article-title":"Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer","volume":"31","author":"Mosele","year":"2020","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e27507_bib58","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.4161\/cc.3.10.1164","article-title":"Oncogenic mutations of PIK3CA in human cancers","volume":"3","author":"Samuels","year":"2004","journal-title":"Cell Cycle"},{"issue":"7418","key":"10.1016\/j.heliyon.2024.e27507_bib59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27507_bib60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrclinonc.2017.151","article-title":"Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others","volume":"15","author":"Sabapathy","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27507_bib61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.118.037934","article-title":"Genetic variants associated with cancer therapy-induced cardiomyopathy","volume":"140","author":"Garcia-Pavia","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27507_bib62","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ymthe.2020.12.029","article-title":"Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer","volume":"29","author":"Thomas","year":"2021","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27507_bib63","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1631\/jzus.B2200292","article-title":"USH2A mutation and specific driver mutation subtypes are associated with clinical efficacy of immune checkpoint inhibitors in lung cancer","volume":"24","author":"Yang","year":"2023","journal-title":"J. Zhejiang Univ. - Sci. B"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27507_bib64","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2008-0171","article-title":"Association between parapneumonic effusion and pericardial effusion in a pediatric cohort","volume":"122","author":"Roberts","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.heliyon.2024.e27507_bib65","first-page":"4159","article-title":"Curative effects of dendritic cells combined with cytokine-induced killer cells in patients with malignant pericardial effusion","volume":"22","author":"Wang","year":"2016","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.heliyon.2024.e27507_bib66","doi-asserted-by":"crossref","DOI":"10.1177\/2040620719827310","article-title":"Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia","volume":"10","author":"Short","year":"2019","journal-title":"Ther Adv Hematol"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e27507_bib67","doi-asserted-by":"crossref","first-page":"9189","DOI":"10.18632\/oncotarget.3279","article-title":"FLT3-ITD confers resistance to the PI3K\/Akt pathway inhibitors by protecting the mTOR\/4EBP1\/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia","volume":"6","author":"Nogami","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27507_bib68","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3324\/haematol.2019.240754","article-title":"Potential targeting of FLT3 acute myeloid leukemia","volume":"106","author":"Ambinder","year":"2021","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27507_bib69","first-page":"279","article-title":"Precision medicine for human cancers with Notch signaling dysregulation","volume":"45","author":"Katoh","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27507_bib70","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12929-022-00788-0","article-title":"Novel FLT3\/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma","volume":"29","author":"Lai","year":"2022","journal-title":"J. Biomed. Sci."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024035382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024035382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T09:25:04Z","timestamp":1753262704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024035382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2405844024035382"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27507","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of machine learning-based malignant pericardial effusion-related model in breast cancer: Implications for clinical significance, tumor immune and drug-therapy","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e27507"}}